Minor Stroke Clinical Trial
— COGaDOMOfficial title:
Mild Cognitive Impairment After Minor Stroke: Evaluation of Early-phase Telecare Programs (Psychoeducation and Computerized Cognitive Stimulation)
Minor strokes (few acute neurological symptoms ; NIHSS score <5), represent almost 65% of cerebrovascular ischemic events. The increasing incidence of stroke in people under 65, together with advances in diagnostic and revascularization techniques, mean that post-stroke life expectancy is now in the order of decades. Most patients with minor stroke are rapidly discharged from hospital, with follow-up focused on secondary prevention and they are offered little or no rehabilitation. However, up to 70% of patients with minor stroke experience difficulties resuming their social or professional activities, which can lead to social and economic disruption (delayed/compromised return to work) and an increased risk of depression. While some care recommendations exist for this population, in France there is no consensus nor identified care pathway for follow-up assessment or management of these patients. Furthermore, existing services are unevenly distributed across the country, and research into the effectiveness of rehabilitation is still scarce, leading to uncertainty as to which interventions should be prioritized to decrease difficulties related to cognitive impairment. Since there are currently no rehabilitation proposals in France for patients with mild cognitive impairment after mild stroke, in this trial the investigaror will investigate the effectiveness of two six-week telerehabilitation programs each consisting of a weekly session supervised by a therapist and a self-rehabilitation session. The aim of this multicenter randomized controlled trial is the evaluate the relevance and feasibility of early identification of patients eligible for a cognition-focused management proposal and the efficacy of two telecare programs, (a) psychoeducation and (b) computerized cognitive rehabilitation.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | July 1, 2027 |
Est. primary completion date | July 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Man or woman, aged between 18 and 65 years old - Hospitalization for a first stroke - Minor stroke: NIHSS score < 5 on discharge from neurovascular unit - Post-stroke delay < 8 weeks - Living at home (not institutionalized) - Affiliated with social security or benefiting from such a scheme - French language - Presence of a cognitive complaint (FACT-Cog "perceived cognitive impairments" subscale score < 55) and absence of major cognitive impairment - Signature of informed consent Exclusion Criteria: - History of stroke - Uncorrected hearing or visual impairment - Neurological pathology other than stroke or disabling psychiatric disorder - Unstabilized epilepsy - Undergoing cognitive rehabilitation in another context or having integrated a post-stroke therapeutic education program - Living in a white zone that does not allow for remote rehabilitation - Unable to connect to the Internet - Pregnant, parturient or breast-feeding women* (interview data) - Persons deprived of their liberty by judicial or administrative decision - Persons admitted to a health or social institution for purposes other than research - Adults under legal protection (guardianship, curatorship) - Taking part in other interventional research involving a period of exclusion still in progress at pre-inclusion |
Country | Name | City | State |
---|---|---|---|
France | CHU de Bordeaux | Bordeaux | |
France | CHU Lille | Lille | |
France | Hôpital Henry Gabrielle | Saint-Genis-Laval |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The primary objective of this study is to demonstrate the benefits of early management following a minor stroke on participation at 6 months post-stroke. | Difference in the Participation score (from the Participation subscale of the stroke impact scale) between the pre-intervention evaluation and the evaluation 6 months post-stroke, between the intervention and non-intervention groups | At the end of the study : 36 months | |
Secondary | to evaluate the effects on quality of life of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs will be evaluated with quality of life measured using the WHOQOL-BREF Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. | At the end of the study : 36 months | |
Secondary | to evaluate the effects on cognitive complaint of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs will be evaluated with cognitive complaint measured using the FACT-Cog;
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months | |
Secondary | to evaluate the effects on cognitive function of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs will be evaluated with cognitive function (notably attentional, executive and memory functions) measured using a custom-designed battery of neuropsychological tests;
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months | |
Secondary | to evaluate the effects on mood and anxiety of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs on mood and anxiety will be measured by the HADS
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months | |
Secondary | to evaluate the effects on fatigue of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs on fatigue will be measured by the FACIT-Fatigue
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months | |
Secondary | to evaluate the effects on participation of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs on participation will be measured by the score on the Participation subscale of the Stroke Impact Scale
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months | |
Secondary | to evaluate the effects on health status of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs on health status will be measured by EQ-5D-5L;
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months | |
Secondary | to evaluate the effects on health status of the proposed programs at post-intervention, 6 months post-stroke and 9 months post-stroke in comparison with measurements taken before the start of management (pre-intervention visit 1) | the effects of the proposed programs on the medico-economic impact of these interventions.
Difference in each outcome measure score between the pre-intervention evaluation and the evaluations post-intervention and at 9 months post-stroke, between the intervention and non-intervention groups. |
At the end of the study : 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04420351 -
Thrombolysis of Urokinase for Minor Stroke
|
Phase 3 | |
Recruiting |
NCT05369637 -
Multiple Interventions to Accelerate the Return to the Pre-event Level of Functioning After a TIA and Minor Stroke
|
N/A | |
Recruiting |
NCT04945174 -
Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions
|
N/A | |
Not yet recruiting |
NCT03079674 -
China Registry of Non-disabling Ischemic Cerebrovascular Events
|
N/A | |
Withdrawn |
NCT02144831 -
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
|
Phase 4 | |
Recruiting |
NCT04917237 -
Non-disabling Ischemic Cerebrovascular Event With Apathy
|